Sarah Waliany: Honored to Receive Young Investigator Award for Research on ALK Inhibitors in NSCLC

Sarah Waliany, a Clinical Fellow in Hematology/Oncology at Dana-Farber Cancer Institute, shared a post on X:

“Thank you Conquer Cancer, the ASCO Foundation, ASCO for granting me the Young Investigator Award for my work investigating resistance to next-gen ALK inhibitors for NSCLC. Enormously grateful for this opportunity and for the incredible mentorship of Jessica Lin, our amazing team, and our patients.”